
Jennifer Mendoza
Research expert covering health, pharma and medtech

Detailed statistics
People with bleeding disorders worldwide in 2024, by condition

Detailed statistics
Number of persons with bleeding disorders worldwide in 2023, by disorder type

Detailed statistics
Distribution of persons with bleeding disorders worldwide in 2024, by gender

People with bleeding disorders worldwide in 2024, by condition
Number of people with bleeding disorders worldwide in 2024, by condition

Number of persons with bleeding disorders worldwide in 2023, by disorder type
Number of people with bleeding disorders worldwide in 2023, by disorder type

Distribution of persons with bleeding disorders worldwide in 2024, by gender
Distribution of people with bleeding disorders worldwide in 2024, by gender

Most common worries for hemophilia patients worldwide as of 2023
Leading concerns reported by people with hemophilia, caregivers, and hematologists worldwide as of 2023

Most common symptoms of hemophilia worldwide as of 2023
Leading hemophilia symptoms in the past 6 months reported by people with hemophilia, caregivers, and hematologists worldwide as of 2023

Negative impacts of hemophilia on patients' life worldwide as of 2023
Percentage of hemophilia patients worldwide who stated hemophilia had a negative impact on select aspects of life as of 2023

Actions taken by hemophilia patients due to their condition worldwide 2023
Percentage of hemophilia patients who took select actions as a result of their condition worldwide as of 2023

Most common emotional experiences of hemophilia patients worldwide 2023 by frequency
Percentage of hemophilia patients worldwide with select emotional experiences as of 2023, by frequency

Impact of medicines on life expectancy for select rare diseases worldwide as of 2017
Life expectancy for individuals with select rare diseases before available treatment and now worldwide as of 2017

Forecasted sales of top hemophilia products worldwide 2026
Forecasted sales of leading hemophilia products worldwide in 2026 (in million U.S. dollars)

Number of persons with bleeding disorders in the U.S. in 2024, by condition
Number of people with bleeding disorders in the United States in 2024, by condition

Number of persons with bleeding disorders in the U.S. in 2023, by type
Number of people with bleeding disorders in the U.S. in 2023, by disorder type

Distribution of U.S. patients with rare factor deficiencies as of 2024, by gender
Distribution of patients in the U.S. with rare factor deficiencies as of 2024, by gender*

Distribution of U.S. patients with platelet disorders as of 2024, by gender
Distribution of patients in the U.S. with platelet disorders as of 2024, by gender*

Hemophilia market size in the U.S. 2022-2030
Hemophilia market size in the United States from 2022 to 2030 (in billion U.S. dollars)

Distribution of people with hemophilia A in the U.S. in 2024, by age group
Distribution of people with hemophilia A in the U.S. in 2024, by age group

Distribution of people with hemophilia B in the U.S. in 2024, by age group
Distribution of people with hemophilia B in the U.S. in 2024, by age group

Number of U.S. male patients with hemophilia A or B from 2012 to 2024, by state
Number of male patients in the U.S. with hemophilia A or B from 2012 to 2024, by state

Distribution of U.S. patients with von Willebrand disease as of 2024, by gender
Distribution of patients in the U.S. with von Willebrand disease (VWD) as of 2024, by gender*

Distribution of U.S. patients with von Willebrand disease as of 2024, by race
Distribution of patients in the U.S. with von Willebrand disease (VWD) as of 2024, by race*

Distribution of people with von Willebrand disease in the U.S. in 2023, by age group
Distribution of people with von Willebrand disease in the U.S. in 2023, by age group

Number of U.S. patients with von Willebrand disease from 2012 to 2024, by state
Number of patients in the U.S. with von Willebrand disease from 2012 to 2024, by state
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.